These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17998117)

  • 21. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
    McKenney JM
    Am J Cardiol; 2005 Aug; 96(4A):60E-66E. PubMed ID: 16098846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
    Bays HE; Davidson MH; Massaad R; Flaim D; Lowe RS; Tershakovec AM; Jones-Burton C
    Am J Cardiol; 2011 Aug; 108(4):523-30. PubMed ID: 21596364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
    Brath H; Wascher TC; Kästenbauer T; Toplak H
    MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid-lowering therapy in older patients with manifest atherosclerotic disease.
    Mendelson G; Aronow WS
    J Am Geriatr Soc; 1998 Sep; 46(9):1128-31. PubMed ID: 9736107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol >or=125 mg/dl treated with statins versus no lipid-lowering drug.
    Aronow WS; Ahn C; Gutstein H
    J Gerontol A Biol Sci Med Sci; 2002 May; 57(5):M333-5. PubMed ID: 11983729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adequacy of control of hypertension in an academic nursing home.
    Koka M; Joseph J; Aronow WS
    J Am Med Dir Assoc; 2007 Oct; 8(8):538-40. PubMed ID: 17931579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H; Mendelsohn AA; Goodman SG; Jaffer S; Chen RY; Tjia S; Theriault L; Langer A; Leiter LA;
    Am J Cardiol; 2009 Sep; 104(6):798-804. PubMed ID: 19733714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins targeting inflammation by lowering low-density lipoprotein?
    Tuzcu EM; Nicholls SJ
    J Am Coll Cardiol; 2007 May; 49(20):2010-2. PubMed ID: 17512356
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can group medical clinics improve lipid management in diabetes?
    Crowley MJ; Melnyk SD; Ostroff JL; Fredrickson SK; Jeffreys AS; Coffman CJ; Edelman D
    Am J Med; 2014 Feb; 127(2):145-51. PubMed ID: 24462012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP
    Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercholesterolemia. The evidence supports use of statins.
    Aronow WS
    Geriatrics; 2003 Aug; 58(8):18-20, 26-8, 31-2. PubMed ID: 12938249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparities in lipid control and statin drug use among diabetics with noncoronary atherosclerotic vascular disease vs those with coronary artery disease.
    Thapa R; Sharma S; Jeevanantham V; Hu C; Myers T; Vacek JL; Dawn B; Gupta K
    J Clin Lipidol; 2015; 9(2):241-6. PubMed ID: 25911081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of adequate control of increased serum low-density lipoprotein cholesterol in self-pay or Medicare patients versus Medicaid or private insurance patients followed in a University General Medicine Clinic.
    Varma R; Aronow WS; Gandelman G; Zammit C
    Am J Cardiol; 2005 Jan; 95(2):269-70. PubMed ID: 15642567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of compliance with lipid guidelines in an academic medical center.
    Schwiesow SJ; Nappi JM; Ragucci KR
    Ann Pharmacother; 2006 Jan; 40(1):27-31. PubMed ID: 16352778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.